Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
45.80
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
382,190
Open
45.80
Bid (Size)
45.04 (100)
Ask (Size)
45.05 (1,000)
Prev. Close
45.80
Today's Range
45.80 - 45.80
52wk Range
35.12 - 81.44
Shares Outstanding
N/A
Dividend Yield
5.57%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Ways to Play the Big Pharma Patent Cliff
↗
Today 7:05 EDT
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize.
Via
MarketBeat
Topics
ETFs
Intellectual Property
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?
↗
Today 5:25 EDT
Hims & Hers continues growing rapidly, but shrinking margins and rising costs are beginning to test the company's long-term profitability story.
Via
The Motley Fool
Topics
Artificial Intelligence
Performance
YTD
-12.6%
-12.6%
1 Month
+16.5%
+16.5%
3 Month
-6.4%
-6.4%
6 Month
-6.8%
-6.8%
1 Year
-28.9%
-28.9%
More News
Read More
Best Healthcare Stocks to Buy in 2026
↗
May 14, 2026
Via
The Motley Fool
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
↗
May 14, 2026
Via
The Motley Fool
Is Novo Nordisk's Rebound for Real--or Just a Head Fake?
↗
May 13, 2026
Via
The Motley Fool
Novo Nordisk A/S Q1 Earnings Call Highlights
↗
May 13, 2026
Via
MarketBeat
Topics
Earnings
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
↗
May 12, 2026
Via
MarketBeat
Topics
Intellectual Property
Lawsuit
Why Hims & Hers Health Stock Just Crashed
↗
May 12, 2026
Via
The Motley Fool
Topics
Earnings
Lawsuit
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
Via
FinancialNewsMedia
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
May 11, 2026
Via
Investor Brand Network
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
Via
Investor Brand Network
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
↗
May 09, 2026
Via
The Motley Fool
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
↗
May 08, 2026
Via
MarketBeat
Forget Eli Lilly: These 2 Stocks Have More Upside
↗
May 07, 2026
Via
The Motley Fool
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
↗
May 07, 2026
Via
MarketBeat
My Top Obesity Stock to Buy and Hold
↗
May 07, 2026
Via
The Motley Fool
Record Highs, Punished Results, and One Very Consequential Apple Rumor
↗
May 06, 2026
Via
Chartmill
3 Absurdly Cheap Growth Stocks to Buy in May 2026
↗
May 04, 2026
Via
The Motley Fool
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
↗
May 04, 2026
Via
The Motley Fool
Eli Lilly Just Announced Fantastic News for Shareholders
↗
May 04, 2026
Via
The Motley Fool
Topics
Earnings
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
↗
May 02, 2026
Via
The Motley Fool
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent
↗
May 01, 2026
Via
MarketBeat
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge
↗
May 01, 2026
Via
MarketBeat
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 45.80
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 05/14/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.